High-affinity neoantigens correlate with better prognosis and trigger potent antihepatocellular carcinoma (HCC) activity by activating CD39(+)CD8(+) T cells

OBJECTIVE: It remains controversial whether tumour mutational burden (TMB) or neoantigens are prognostic markers in hepatocellular carcinoma (HCC). This study aimed to define the function of TMB or neoantigens in antitumour immunotherapy. DESIGN: Neoantigens of patients (n=56) were analysed by pVAC...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Ting, Tan, Jizhou, Wu, Minhao, Fan, Wenzhe, Wei, Jialiang, Zhu, Bowen, Guo, Jian, Wang, Shutong, Zhou, Penghui, Zhang, Hui, Shi, Liangrong, Li, Jiaping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Hepatology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8458084/
https://www.ncbi.nlm.nih.gov/pubmed/33262196
http://dx.doi.org/10.1136/gutjnl-2020-322196

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8458084/
https://www.ncbi.nlm.nih.gov/pubmed/33262196
http://dx.doi.org/10.1136/gutjnl-2020-322196

Ejemplares similares